FindTrial
Sign In

A Study to Establish Method of Prognostic Prediction for Uterine Mesenchymal Tumor by Immunohistological Biomarkers

A Study to Establish Method of Prognostic Prediction for Uterine Mesenchymal Tumor by Immunohistological Biomarkers - PRUM-IBio study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000038789
Enrollment
390
Registered
2019-12-04
Start date
2019-11-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Clinical Research Center, NHO Kyoto Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: NR

Exclusion criteria

Exclusion criteria: NR

Design outcomes

Primary

MeasureTime frame
NR—

Countries

Japan

Contacts

Public ContactTakuma Hayashi

NHO Kyoto Medical Center Cancer Medicine

nho.kmc.rc@hotmail.com075-641-9161

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026